Holding(s) in Company
May 24 2006 - 9:40AM
UK Regulatory
RNS Number:5118D
Cambridge Antibody Tech Group PLC
24 May 2006
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Name of company
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC
2. Name of shareholder having a major interest
BARCLAYS PLC
3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18
GERRARD LIMITED NOT DISCLOSED
BARCLAYS LIFE ASSURANCE CO LIMITED NOT DISCLOSED
BARCLAYS CAPITAL SECURITIES LIMITED NOT DISCLOSED
BARCLAYS CAPITAL INC NOT DISCLOSED
BARCLAYS GLOBAL INVESTORS LIMITED NOT DISCLOSED
4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them
GERRARD LIMITED 890
BARCLAYS LIFE ASSURANCE CO LIMITED 63,867
BARCLAYS CAPITAL SECURITIES LIMITED 886,842
BARCLAYS CAPITAL INC 170,000
BARCLAYS GLOBAL INVESTORS LIMITED 618,986
5. Number of shares / amount of stock acquired
NOT DISCLOSED
6. Percentage of issued class
N/A
7. Number of shares / amount of stock disposed
NOT DISCLOSED
8. Percentage of issued class
N/A
9. Class of security
ORDINARY 10 PENCE SHARES
10. Date of transaction
17 MAY 2006
11. Date company informed
22 MAY 2006
12. Total holding following this notification
1,740,585
13. Total percentage holding of issued class following this notification
3.27%
14. Any additional information
NONE
15. Name of contact and telephone number for queries
JUSTIN HOSKINS 01223 898589
16. Name and signature of authorised company official responsible for making
this notification
JUSTIN HOSKINS, COMPANY SECRETARY
Date of notification
24 MAY 2006
The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEADSLADPKEFE
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2023 to Jul 2024